Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

BioScience Health Innovations (BHIC) Revenue (2023 - 2025)

BioScience Health Innovations (BHIC) has disclosed Revenue for 3 consecutive years, with $1.6 million as the latest value for Q4 2025.

  • Quarterly Revenue rose 157.74% to $1.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.7 million through Dec 2025, up 208.34% year-over-year, with the annual reading at $5.7 million for FY2025, 208.34% up from the prior year.
  • Revenue for Q4 2025 was $1.6 million at BioScience Health Innovations, up from $1.1 million in the prior quarter.
  • The five-year high for Revenue was $1.8 million in Q2 2025, with the low at $32337.0 in Q1 2023.
  • Average Revenue over 3 years is $677606.5, with a median of $478571.5 recorded in 2024.
  • The sharpest move saw Revenue skyrocketed 758.46% in 2024, then soared 97.47% in 2025.
  • Over 3 years, Revenue stood at $303628.0 in 2023, then surged by 100.98% to $610222.0 in 2024, then skyrocketed by 157.74% to $1.6 million in 2025.
  • According to Business Quant data, Revenue over the past three periods came in at $1.6 million, $1.1 million, and $1.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.